FREE Webinar

Tuesday, May 12, 2020
2:30 - 4:00 PM, Eastern Standard Time

Register/Watch On-Demand Now

Cancer vaccines target unique antigens on tumors, including overexpressed healthy proteins or virus-derived proteins. Each individual tumor is unique, carrying its own distinguishing antigens, which can complicate the cancer vaccine development process. To better characterize, identify, and understand the dynamic interactions between the immune system and cancer cell antigens, researchers can turn to advanced flow cytometry and live-cell imaging technologies. This webinar, brought to you by The Scientist and sponsored by Sartorius, will present new research and developments in the cancer vaccine field, and delve into the intricacies of target discovery and vaccine development.

Topics to be covered

  • Developing breast cancer vaccines with dendritic cell tumor fusions
  • Boosting immunity with cancer vaccines: A focus on breast and ovarian cancer immunology

Register/Watch On-Demand Now

Meet the Speakers:

David E. Avigan, MD
Professor of Medicine

Mary L. (Nora) Disis, MD
Helen B. Slonaker Endowed Professor for Cancer Research
American Cancer Society Clinical Research Professor
Professor, Medicine, Adjunct Professor Pathology and Obstetrics and Gynecology, University of Washington
Director, UW Medicine Cancer Vaccine Institute

Interested in reading more?

The Scientist ARCHIVES

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?